Emerald Health Therapeutics obtained approval from PEI and Manitoba to supply recreational marijuana products.
Emerald Health Therapeutics (TSXV:EMH,OTCQX:EMHTF) obtained approval from PEI and Manitoba to supply recreational marijuana products.
As quoted in the press release:
Emerald has also fulfilled its first shipments of premium cannabis products to PEI Cannabis and to licensed private retailers in Saskatchewan.
“We are pleased to have the opportunity to serve additional provinces,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald. “We believe that our growing nationwide presence reflects the recognition of Emerald as a reliable and consistent cannabis supplier. We look forward to continuing to expand our supply of quality Emerald cannabis products to the Canadian adult-use market.”
Emerald is currently delivering cannabis to the Ontario Cannabis Retail Corporation, Cannabis Retail Store (CRS), the British Columbia Liquor Distribution Board (BCLDB), the Newfoundland Labrador Liquor Corporation, and the Yukon Liquor Corporation. It has also signed a letter of intent with the Société Québécoise du Cannabis (SQDC) to supply cannabis to Quebec and a sales agreement with the Alberta Gaming, Liquor and Cannabis (AGLC) to supply cannabis to Alberta.